The Predictive Value of Urinary Twist1 Methylation and VI-RADS Score for Residual Tumor Before re-TURBT in NMIBC Patients
The predictive model combining VI-RADS score, urinary Twist1 methylation, and visible hematuria exhibits excellent diagnostic performance for predicting residual tumor burden in NMIBC patients, offering significant guidance for clinical practice.
Authors
- Hao Yang (ORCID: https://orcid.org/0000-0003-4172-012X)
- Qisheng Lin (ORCID: https://orcid.org/0000-0001-7244-7213)
- Yaqiang Huang
- Weiyang Wei
- Linfeng Li (ORCID: https://orcid.org/0000-0002-8736-6464)
- Qi Wang (ORCID: https://orcid.org/0000-0003-0962-4218)
Institutions
- Zhongshan People's Hospital (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Urologia Internationalis
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1159/000546718
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01